Jeff Evanson
2021
In 2021, Jeff Evanson earned a total compensation of $300K as Chief Commercial Officer at Outlook Therapeutics, a 88% increase compared to previous year.
Compensation breakdown
| Other | $300,000 |
|---|---|
| Total | $300,000 |
Evanson received $300K in other compensation, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Jeff Evanson's compensation ranked 11,602nd out of 12,397 executives tracked by ExecPay. In other words, Evanson earned more than 6.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,602 out of 12,397 | 6th |
Division Manufacturing | 5,103 out of 5,492 | 7th |
Major group Chemicals And Allied Products | 2,252 out of 2,367 | 5th |
Industry group Drugs | 1,998 out of 2,090 | 4th |
Industry Biological Products, Except Diagnostic Substances | 440 out of 452 | 3rd |
Source: SEC filing on January 27, 2022.
Evanson's colleagues
We found three more compensation records of executives who worked with Jeff Evanson at Outlook Therapeutics in 2021.
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021